RESUMEN
The objective of the present study was to isolate alpha 1,3-galactosyltransferase (GalGT)-gene double knockout (DKO) cells using a novel simple method of cell selection method. To obtain GalGT-DKO cells, GalGT-gene single knockout (SKO) fetal fibroblast cells were cultured for three to nine passages and GalGT-null cells were separated using a biotin-labeled IB4 lectin attached to streptavidin-coated magnetic beads. After 15-17 days of additional cultivation, seven GalGT-DKO cell colonies were obtained from a total of 2.5 x 10(7) GalGT-SKO cells. A total of 926 somatic nuclear transferred embryos reconstructed with the DKO cells were transferred into eight recipient pigs, producing four farrowed, three liveborns, and six stillborns. Absence of GalGT gene in the cloned pigs was confirmed by PCR and Southern blotting. Flow cytometric analysis revealed that alphaGal antigens were not present in the cells of the cloned DKO pigs.
Asunto(s)
Separación Celular/métodos , Disacáridos/deficiencia , Galactosiltransferasas/genética , Técnicas de Transferencia Nuclear , Porcinos , Animales , Animales Modificados Genéticamente , Antígenos/genética , Antígenos/metabolismo , Células Cultivadas , Clonación de Organismos/métodos , Disacáridos/genética , Disacáridos/inmunología , Femenino , Fibroblastos/citología , Fibroblastos/metabolismo , Humanos , Magnetismo , Masculino , Embarazo , Porcinos/genética , Porcinos/inmunología , Trasplante HeterólogoRESUMEN
BACKGROUND: Expression of complement regulatory proteins (CRP) on pig endothelial cells (PEC) is an effective means of avoiding induction of hyperacute rejection by human sera. However, pig endogenous retrovirus (PERV) from PEC transfected with CRP may acquire resistance to human sera. This study investigated a form of transfected CRP that is easily expressed on PERV particles. METHODS: The PEC line was transfected with the Lac Z gene and PERV-B to investigate PERV infectivity using a Lac Z pseudo-type assay. The cDNAs of several modified DAF (CD55) were then transfected into the PEC(Lac Z)/P-B lines using lipofection. DAF expression was verified by FACS analysis. Complement-dependent PEC lysis was tested to verify the complement regulatory function of the expressed DAF. HEK293 cells were incubated with PEC culture supernatants with or without human sera. The inoculated 293 cells were histochemically stained and Lac Z-positive blue foci were counted. The rate of reduction in Lac Z-positive cells resulting from the addition of human serum was then calculated. In addition, to assess the localization of the expressed DAF, flotation sucrose density analysis was performed. RESULTS: While PERV released from PEC expressing delta-short consensus repeat 2 (delta-SCR2) DAF (lacking CRP function) showed no change in resistance to human serum compared to control cells, PERV from cells expressing delta-SCR1 DAF (with CRP function) showed a significant increase in resistance. The DAF-blocking antibody assay indicated that PERV from the DAF transfectants expressed DAF molecules on the surface of the retrovirus. While delta-SCR1 DAF (PI-anchor form) significantly inhibited the reduction of Lac Z-positive cells by human serum, the reduction of Lac Z-positive cells by human serum was less inhibited in the case of transmembrane (TM)-types of DAF-HLA-G, modified influenza hemagglutinin (HA) and MCP (delta-CYT form). However, the reduction in each TM-type DAF was slightly less than that observed in naive and mock cells. The flotation sucrose density analysis of these transfectants indicated that the PI-anchor form of DAF is a raft-associated protein, and most TM-types of DAF are non-raft proteins. CONCLUSION: Induction of resistance to human serum in PERV, depends on the form of the CRP tail. The CRP/TM hybrid that does not associate with lipid rafts, is a suitable form of CRP for gene transduction.
Asunto(s)
Antígenos CD55/genética , Antígenos CD55/inmunología , Retroviridae/inmunología , Suero/inmunología , Porcinos/inmunología , Porcinos/virología , Secuencia de Aminoácidos , Animales , Anticuerpos/sangre , Anticuerpos/inmunología , Antígenos CD55/química , Línea Celular , Humanos , Datos de Secuencia Molecular , Mutación/genética , Porcinos/genética , TransfecciónRESUMEN
Organ transplantation is now effective therapies across a wide range of both fatal and non-fatal diseases. The excellent survival and success rates of organ transplantation have led to high levels of demand globally. The demand has outstripped the supply of organs from both deceased donors and from the altruistic living relatives of patients in need. Increasing use, over the past 10 years, of living donation of nonregenerative organs has extended from kidneys to livers, lungs and pancreas in some instances, despite the hope that reliance on living donors could be reduced. And, it is clear that ethically-unacceptable practices occur in a number of countries. The 1991 World Health Organization (WHO) Guiding Principles (GP) have influenced national legislation and professional codes but over the last 10 years many transplantation practices are no longer in line with the GP. The GP will be revised in 2008. While xenotransplantation offers a potential solution to the demand, 3 problems need to be overcome, i.e. inadequate physiological function, rejection of the graft, and the risk of transmitting a serious and/or novel infectious disease to the human recipient and wider public.
Asunto(s)
Trasplante de Órganos/tendencias , Donantes de Tejidos , Trasplante Homólogo , Trasplante de Corazón/estadística & datos numéricos , Trasplante de Corazón-Pulmón/estadística & datos numéricos , Humanos , Trasplante de Riñón/estadística & datos numéricos , Trasplante de Hígado/estadística & datos numéricos , Donadores Vivos/estadística & datos numéricos , Trasplante de Órganos/estadística & datos numéricos , Donantes de Tejidos/estadística & datos numéricos , Trasplante HeterólogoRESUMEN
The pig cDNA encoding C1 esterase inhibitor (C1-INH) was isolated and the homology of the sequence was compared with that from other animals. The structure of pig C1-INH contains a two disulfide bridge pattern identical to the human C1-INH. In the amino acid sequence of the first Cys-91 to the C-terminal end, the pigC1-INH has a 76.2% homology with the human protein, and the sequence of the reactive site is close to the human. A surface-bound form of pig and human C1-INH, pC1-INH-PI and hC1-INH, respectively, were next constructed. Stable Chinese hamster ovarian tumor (CHO) cell lines and pig endothelial cell (PEC) lines expressing these C1-INH-PI were prepared by transfection. The basic function and the species specificity of pCI-INH were then investigated using these transfectants. pC1-INH and hC1-INH have almost the same suppressive effect on pig, human, dog and rabbit sera in complement-dependent cell lysis, indicating little species specificity.
Asunto(s)
Proteínas Inactivadoras del Complemento 1/genética , Sus scrofa/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células CHO , Clonación Molecular , Cricetinae , Cricetulus , Cartilla de ADN , ADN Complementario/genética , Citometría de Flujo , Humanos , Immunoblotting , Datos de Secuencia Molecular , Alineación de Secuencia , Análisis de Secuencia de ADN , Especificidad de la EspecieRESUMEN
BACKGROUND: It is difficult to produce a transgenic animal with high expression of decay-accelerating factor (CD55: DAF) or other molecules. The purpose of this study was to assess the effect of tandem forms of DAF on a xenogeneic cell membrane against human complement. METHODS: cDNAs of the delta-Short Consensus Repeat (SCR) 1-DAF, the double-DAF, the triple-DAF, and the tetra-DAF with a FLAG-tag were established. Chinese hamster ovary (CHO) cell lines and a pig endothelial cell (PEC) line expressing these molecules were established. The amelioration of complement-mediated lysis by the transfectant molecules on these cells was examined. The CHO cell transfectants were also incubated with normal human serum, and the amount of C3 deposited was determined by FACS analysis. RESULTS: Stable CHO cells and PEC transfectants, in which each molecule was clearly expressed, and Western blots showed that each band corresponded to the expected molecular weight. The extent of amelioration of complement-mediated lysis by these four molecules was then examined. A clear tendency was found, as follows: The higher the tandem number of DAF, the greater was the effect on cytotoxicity. Additional experiments focusing on triple-DAF and tetra-DAF did not indicate any significant difference in complement-mediated lysis. Consistent with the complement-regulatory ability, the inhibitory effect of the deposition of C3 fragments by these molecules was closely related to the degree of amelioration. CONCLUSION: These data indicate that tandem DAF, especially a triple-DAF, is a very effective form for protecting against complement activation.
Asunto(s)
Antígenos CD55/farmacología , Activación de Complemento/efectos de los fármacos , Citotoxicidad Inmunológica/efectos de los fármacos , Trasplante Heterólogo/inmunología , Animales , Antígenos CD55/genética , Células CHO , Secuencia de Consenso , Cricetinae , ADN Complementario , Citometría de Flujo , Secuencias Repetitivas de Ácidos Nucleicos , Porcinos , TransfecciónRESUMEN
BACKGROUND: The pig pancreas is considered to be the most suitable source of islets for xenotransplantation in patients with type I diabetes. The objective of this study was to assess the antigenicity of neonatal porcine islet-like cell clusters (NPCC), including the Galalpha1-3Galbeta1-4GlcNAc-R (alpha-Gal) and Hanganutziu-Deicher (H-D) antigens, and the pathway involved in human complement activation. The efficiency of expression of human decay-accelerating factor (DAF: CD55) on NPCC by adenoviral transduction was also examined, and the functional capacity of DAF was also estimated. METHODS: The deposition of human natural antibodies, immunoglobulin (Ig)G and IgM, and the expression of alpha-Gal and H-D antigens on NPCC were investigated by FACS analysis. The downregulation in the antigenicity to human natural antibodies, including the alpha-Gal and H-D antigens on NPCC by treatment with tunicamycin, PDMP and neuraminidase were also examined. In addition, complement-mediated islet lysis was examined using factor D-deficient and C1-deficient sera. An adenovirus encoding DAF under the control of the cytomegalovirus promoter, Ad.pCMV-DAF, was then constructed, and used for transducing NPCC. The amelioration of complement-dependent cytotoxicity of the NPCC by the transduced DAF was assessed as an in vitro hyperacute rejection model of a pig to human xenograft. RESULTS: The NPCC clearly expressed the alpha-Gal epitope, and the human natural antibodies, IgG and IgM, and the anti-H-D antibody also reacted with the NPCC. Treatment of NPCC with tunicamycin led to a drastic reduction in the extent of deposition of IgG, indicating the importance of N-linked sugars on the islets, presumably related to alpha-Gal expression on N-linked sugars. Neuraminidase treatment indicated the presence of, not only the H-D antigen, but also other sialic acid antigens which reacted with the human natural antibody, especially IgG. The complement deposition of factor B on NPCC was clear, and the alternative pathway-mediated NPCC killing accounted for approximately 30% of that by the total complement pathway. On the other hand, approximately 90% of the NPCC could be transduced to express DAF by the adenovector, Ad.pCMV-DAF. The expressed DAF showed an approximately 50-62% suppression in complement-dependent NPCC lysis. CONCLUSION: The origin of the antigenicity of NPCC is mainly N-linked sugars including alpha-Gal and sialic acid antigens, and NPCC expressed the transduced molecule in high efficiency by the adenovector.
Asunto(s)
Antígenos Heterófilos/inmunología , Antígenos CD55/biosíntesis , Islotes Pancreáticos/citología , Trasplante Heterólogo/inmunología , Adenoviridae/genética , Animales , Animales Recién Nacidos/inmunología , Fenómenos Fisiológicos Sanguíneos , Activación de Complemento , Complemento C3/inmunología , Complemento C4/inmunología , Factor B del Complemento/inmunología , Femenino , Vectores Genéticos , Humanos , Islotes Pancreáticos/efectos de los fármacos , Trasplante de Islotes Pancreáticos/inmunología , Masculino , Morfolinas/farmacología , Neuraminidasa/farmacología , Oligosacáridos/inmunología , Porcinos , Tunicamicina/farmacologíaRESUMEN
HLA-E functions as an inhibitory signaling molecule of natural killer (NK) cell-mediated cytolysis. However, the cell surface expression of HLA-E molecules is quite restricted because of the limited repertoire of binding peptide sequences, such as signal peptides of other HLA molecules, especially on xenogeneic cells. In this study, we successfully determined that position-147 is an important amino acid position for cell surface expression by producing point substitutions. For further studies concerning transplantation therapy, the point substitution, Ser147Cys, that resulted in a single atom change, oxygen to sulfur, designated as HLA-Ev(147), led to a much higher expression on the human and pig cell surface and a greater inhibitory function against human NK cells than wild type HLA-E in an in vitro model system of pig to human xenotransplantation. Consequently, HLA-Ev(147) might be a promising alternative gene tool for future transplantation therapy such as xenotransplantation.
Asunto(s)
Expresión Génica , Antígenos HLA/metabolismo , Secuencia de Aminoácidos , Animales , Línea Celular , Cricetinae , Citoplasma/metabolismo , Antígenos HLA/genética , Humanos , Células Asesinas Naturales/metabolismoRESUMEN
BACKGROUND: Porcine endogenous retrovirus (PERV) released from pig cells is a main problem associated with clinical xenotransplantation. In a previous study, we demonstrated that the high mannose type of N-glycan of the envelope glycoprotein is closely related to PERV infectivity with respect to human cells. In this study, we addressed the effects of reducing the high mannose type of N-glycan on PERV infectivity. METHODS: Pig endothelial cells (PEC) were transduced with the LacZ gene by a pseudotype infection to produce PEC(Z). The PEC(Z)s were then further infected with PERV subtype B (PERV-B) to produce PEC(Z)/PB. The PEC(Z)/PBs were next transfected with the alpha 1,2 mannosidase Ib (Man Ib), N-acetylglucosaminyltransferase I (GnT-I) or alpha-mannosidase II (Man II) gene in order to reduce the levels of high mannose type of N-glycan. HEK293 cells were inoculated with the PERV in each of the culture supernatants. The inoculated cells were histochemically stained and the LacZ-positive cells were counted. RESULTS: In experiment I, PERV transmission from the PEC(Z)/PB with GnT-I or Man II to HEK 293 cells was significantly reduced in comparison with control PEC(Z)/PB, while the PEC(Z)/PB with Man Ib was not. However, in experiment II, PERV transmission from the PEC(Z)/PB with ManIb to HEK 293 cells was also significantly reduced in comparison with control PEC(Z)/PB. CONCLUSION: The transfection of these genes to pig cells is effective in reducing the susceptibility of human cells to PERV infection. The results suggest that this represents a potentially useful strategy for further decreasing the likelihood of PERV infections.
Asunto(s)
Retrovirus Endógenos/patogenicidad , Infecciones por Retroviridae/prevención & control , Trasplante Heterólogo , Proteínas del Envoltorio Viral/genética , Animales , Línea Celular , Retrovirus Endógenos/genética , Humanos , Riñón , Reacción en Cadena de la Polimerasa , Porcinos , Transducción Genética , alfa-Manosidasa/metabolismoRESUMEN
Xenotransplantation is one of the most attractive solutions for the current worldwide shortage of organs. The knocking out of alpha1,3-galactosyltransferase in pigs resulted in a drastic reduction in xenoantigenicity. However, more recent studies indicate that other xeno-antigens, so-called non-Gal antigens, will also need to be downregulated. In this study, pig N-acetylglucosaminyltransferase I (GnT-I), a key enzyme that initiates the biosynthesis of hybrid- and complex-type N-linked sugar chains, was isolated and the pigGnT-I.2 specific for the O-linked sugar chain was also isolated. Point mutants, pigGnT-I(123) and pigGnT-I(320), were subsequently constructed. While pigGnT-I(123) shows an indistinct dominant negative effect for endogenous GnT-I in pig cells, pigGnT-I(320) had a drastic effect. In addition, in the case of pig cell transfectants with pigGnT-I(320), cell surface carbohydrate structures were significantly altered and its antigenicity to human serum was reduced. Consequently, pigGnT-I(320) appears to be potentially useful in xenotransplantation by remodeling the carbohydrate structures on pig cells.
Asunto(s)
N-Acetilglucosaminiltransferasas/genética , Porcinos/genética , Porcinos/inmunología , Trasplante Heterólogo , Secuencia de Aminoácidos , Animales , Antígenos Heterófilos/química , Antígenos Heterófilos/inmunología , Secuencia de Bases , Carbohidratos/química , Carbohidratos/inmunología , Línea Celular , Clonación Molecular , Activación de Complemento , Cobayas , Datos de Secuencia Molecular , Mutación Puntual , TransfecciónRESUMEN
We studied the expression of 9,906 genes in retransplanted rat cardiac allografts that developed cardiac allograft vasculopathy (CAV) with the use of DNA microarray and real-time reverse transcriptase-polymerase chain reaction. Although only a slight difference in the timing of the retransplantation induced the later development of CAV, 1,067 genes were differentially expressed in the allografts 1 day after retransplantation. Thus, the development of CAV was determined by a robust difference in gene expression soon after retransplantation, controlled by a slight difference in retransplantation timing. In contrast, only 26 genes showed significant upregulation in the later phase of CAV development, and the time-course of the induction of 16 genes was associated with CAV progression. Of these genes, 8 were induced in 2 different aortic allograft combinations, and the time-course of the induction was correlated with the development of transplant vasculopathy. Microarray-based gene expression profiling has the potential to elucidate the mechanism of experimental chronic cardiac allograft rejection.
Asunto(s)
Perfilación de la Expresión Génica , Rechazo de Injerto/genética , Rechazo de Injerto/fisiopatología , Trasplante de Corazón , Análisis de Secuencia por Matrices de Oligonucleótidos , Enfermedades Vasculares/genética , Animales , Ratas , Ratas Endogámicas Lew , Ratas Wistar , Reoperación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transcripción Genética , Trasplante Heterotópico , Trasplante Homólogo , Enfermedades Vasculares/etiología , Enfermedades Vasculares/fisiopatologíaAsunto(s)
Porcinos , Trasplante Heterólogo , Animales , Animales Modificados Genéticamente , Reacciones Antígeno-Anticuerpo/inmunología , Activación de Complemento , Galactosiltransferasas/inmunología , Rechazo de Injerto/inmunología , Haplorrinos , Humanos , Porcinos/microbiología , Porcinos/parasitología , Porcinos/virología , Trasplante Heterólogo/ética , Trasplante Heterólogo/inmunologíaRESUMEN
The possibility of preventing the transmission of porcine endogenous retrovirus (PERV) to human cells using short interfering RNAs (siRNA) was investigated. The siRNA for the p30 of PERV gag region was cloned into pSUPER, the polymerase-III H1-RNA gene promoter. A green fluorescence protein (GFP) was also cloned into pSUPER to establish pSXGH. Pig endothelial cells (PEC) were transduced with the LacZ gene by pseudotype infection, and infected with PERV subtype B, resulting in the formation of PEC(LacZ)/PB. The PEC(LacZ)/PB was next transfected with pSXGH-siRNA. The expression of siRNA was provisionally checked by determining the level of expression of GFP. Culture supernatants of infected cells were then inoculated into HEK293 cells. The siRNA clearly destroyed the PERV infectivity of PEC(LacZ)/PB in both transient cell lines and stable clones. Moreover, the decreased levels of mRNA and gag protein were evidenced in the stable clones by real-time PCR and Western blotting, respectively. The final goal of our study was to establish a transgenic pig expressing the siRNA for PERV. The results suggest that siRNA represents a novel approach for controlling PERV infections in clinical xenotransplantation.
Asunto(s)
Retrovirus Endógenos/patogenicidad , ARN Interferente Pequeño/uso terapéutico , Infecciones por Retroviridae/prevención & control , Trasplante Heterólogo/efectos adversos , Animales , Animales Modificados Genéticamente , Células Cultivadas , Humanos , Interferencia de ARN , Infecciones por Retroviridae/transmisión , PorcinosRESUMEN
Heterozygous alpha 1,3-galactosyltransferase (GT) gene knockout pigs were produced with transgenic pig fetal cells expressing both human decay-accelerating factor (hDAF) and N-acetylglucosaminyltransferase III (GnT-III). In this study, we assessed the gene targeting efficiency in the transgenic pig fetal cells derived from different fetal tissues such as brain, skin, heart, and liver, or fetal carcass. Targeted cell colonies were selected by hygromycin B. The GT-knockout colonies (KO colonies) were obtained equally from the cells derived from all tissues except liver. Staining with five antibodies against intermediate filaments, all examined KO cell lines stained positive for vimentin with the exception of a colony that stained positive for both vimentin and glial fibrillary acidic protein simultaneously. This is the first study to produce KO cells from the astrocytes. Some of these KO cell lines were used for nuclear transfer (NT) to obtain KO pig fetuses. Fourteen fetuses were obtained from two recipients of the embryo transfer and eight of them had normal ploidy. The cells from the KO pig fetuses were also used for NT to produce cloned KO pigs. Two healthy clone pigs were born. These pigs were determined to have a heterozygous knockout GT gene and the two transgenes. The cells collected from the KO pigs were shown to have similar expression levels of hDAF and GnT-III compared to their original transgenic pigs and less than a half levels of the alphaGal epitopes existed in wild-type pig cells.
Asunto(s)
Animales Modificados Genéticamente/genética , Antígenos CD55/genética , Clonación de Organismos , Galactosiltransferasas/deficiencia , N-Acetilglucosaminiltransferasas/genética , Porcinos/genética , Animales , Antígenos CD55/biosíntesis , Expresión Génica , Humanos , N-Acetilglucosaminiltransferasas/biosíntesisRESUMEN
BACKGROUND: Because of a severe shortage of human donor pancreases, pig islets are considered to be an attractive donor source. Our previous in vitro study revealed that adult pig islets have strong non-Galalpha1-3Galbeta1-4GlcNAc-R (alpha-Gal) antigenicity, including the Hanganutziu-Deicher (H-D) antigen, especially in N-linked sugars. In this study, the issue of whether islets from N-acetylglucosaminyltransferase-III (GnT-III) transgenic pigs can prolong their survival in cynomolgus monkeys was examined. METHODS: Adult pig islets were isolated from transgenic pigs with GnT-III and wild-type genes. GnT-III enzyme activity in pig islets was measured by high performance liquid chromatography (HPLC). The antigenicity of the islets to human natural antibodies was examined by flow cytometry. Pig islets were transplanted under the kidney capsule of streptozotocin-induced diabetic monkeys. After transplantation, blood samples were obtained and plasma insulin levels were monitored on a daily basis. RESULTS: While GnT-III was barely expressed in wild-type islets, it was expressed at high levels in islets from transgenic pigs, and xenoantigenicity was significantly reduced. There was a trend for islets isolated from GnT-III-transgenic pigs to survive longer than those from wild-type pigs in cynomolgus monkeys (wild type: 1, 1, and 3 days; GnT-III: 1, >3, 4 and 5 days). Humoral and histological studies indicated up-regulated anti-pig islet antibodies and a relatively high deposition in islet grafts from wild-type pigs, respectively. CONCLUSION: A reduction in xenoantigenicity by GnT-III may have prolonged the survival of porcine islets, suggesting the importance of non-alpha-Gal and non-H-D antigens, as they relate to N-linked sugars in the early rejection of porcine islets in the monkey. This approach may be useful in the clinical xenotransplantation of islets in the future.
Asunto(s)
Diabetes Mellitus Experimental/cirugía , Supervivencia de Injerto , Trasplante de Islotes Pancreáticos , Macaca fascicularis , N-Acetilglucosaminiltransferasas/metabolismo , Porcinos/metabolismo , Trasplante Heterólogo , Animales , Animales Modificados Genéticamente , Anticuerpos Heterófilos/metabolismo , Antígenos Heterófilos/metabolismo , Diabetes Mellitus Experimental/patología , Humanos , Islotes Pancreáticos/enzimología , Islotes Pancreáticos/inmunología , Trasplante de Islotes Pancreáticos/inmunología , Riñón/patología , Riñón/cirugía , Porcinos/inmunología , Trasplante Heterólogo/inmunologíaRESUMEN
BACKGROUND: Our previous study reported that cynomolgus monkey did not hyperacutely reject a skin xenograft from a N-acetylglucosaminyltransferase III (GnT-III) transgenic pig. In the present study, we reported on the survival time of skin xenografts in GnT-III, DAF (CD55), and double (D/G) transgenic pigs, and the effect of FK506 thereon. MATERIAL AND METHODS: Skin from GnT-III, DAF and D/G transgenic pigs were transplanted to cynomolgus monkeys. Under general anesthesia, full thickness skin defects (1.5 x 1.5 cm each) were made on the back of the monkey. Pig abdominal skin, obtained using an electric dermatome, was cut into pieces and transplanted onto the monkey wounds and fixed. In addition, skins of GnT-III and D/G pigs were also transplanted to cynomolgus monkeys that had been treated intramuscularly with FK506 at a dose of 0.5 mg/kg/day for 14 days after transplantation. Grafts were observed and photographed each day and skin graft biopsies were done on days 3, 5, 7, 10, 11, 14, 21, 28 and 31 after transplantation. Graft rejection was assessed histologically, based on our previous criteria for skin allografts. RESULTS: Even in the immuno-suppressive drug free condition, skin xenografts of GnT-III, DAF and D/G transgenic pigs were not hyperacutely rejected in early phase after transplantation by the cynomolgus monkey. The pattern of these xenograft rejections was histologically similar to those for rat allograft rejections. Most of the GnT-III, DAF and D/G pig skin grafts remained nearly intact up to day 5, but slight lymphocyte infiltration was noted on day 7 (grade 1). On day 9, while the GnT-III skin showed moderate lymphocyte and eosinophilic infiltration, the DAF and D/G pig skin grafts showed complete epidermal separation (grade 3). On the other hand, in the case of cynomolgus monkeys treated with FK506, the GnT-III skin showed complete epidermal separation (grade 3) on day 21. In addition, one of the D/G skin graft was intact on day 21 and moderate lymphocyte infiltration and intraepidermal blister formation (grade 1) was finally seen on day 31. CONCLUSION: Our data show the possibility that both the DAF and GnT-III double transgenic pig skin xenografts can be used in place of human skin allografts in cases of severe burns.
Asunto(s)
Antígenos CD55/genética , Supervivencia de Injerto/genética , N-Acetilglucosaminiltransferasas/genética , Trasplante de Piel , Porcinos/genética , Animales , Animales Modificados Genéticamente , Antígenos CD55/inmunología , Supervivencia de Injerto/efectos de los fármacos , Supervivencia de Injerto/inmunología , Inmunosupresores/farmacología , Macaca fascicularis , N-Acetilglucosaminiltransferasas/metabolismo , Porcinos/inmunología , Porcinos/metabolismo , Tacrolimus/farmacología , Factores de Tiempo , Trasplante HeterólogoRESUMEN
NK cells play a critical role in the rejection of xenografts. In this study, we report on an investigation of the effect of complement regulatory protein, a decay accelerating factor (DAF: CD55), in particular, on NK cell-mediated cytolysis. Amelioration of human NK cell-mediated pig endothelial cell (PEC) and pig fibroblast cell lyses by various deletion mutants and point substitutions of DAF was tested, and compared with their complement regulatory function. Although wild-type DAF and the delta-short consensus repeat (SCR) 1-DAF showed clear inhibition of both complement-mediated and NK-mediated PEC lyses, delta-SCR2-DAF and delta-SCR3-DAF failed to suppress either process. However, delta-SCR4-DAF showed a clear complement regulatory effect, but had no effect on NK cells. Conversely, the point substitution of DAF (L147 x F148 to SS and KKK(125-127) to TTT) was half down-regulated in complement inhibitory function, but the inhibition of NK-mediated PEC lysis remained unchanged. Other complement regulatory proteins, such as the cell membrane-bound form factor H, fH-PI, and C1-inactivator, C1-INH-PI, and CD59 were also assessed, but no suppressive effect on NK cell-mediated PEC lysis was found. These data suggest, for DAF to function on NK cells, SCR2-4 is required but no relation to its complement regulatory function exists.
Asunto(s)
Antígenos CD55/fisiología , Proteínas Inactivadoras de Complemento/fisiología , Citotoxicidad Inmunológica , Regulación hacia Abajo/inmunología , Células Asesinas Naturales/inmunología , Sustitución de Aminoácidos/genética , Animales , Western Blotting , Antígenos CD55/biosíntesis , Antígenos CD55/sangre , Antígenos CD55/genética , Línea Celular , Radioisótopos de Cromo/metabolismo , Activación de Complemento/genética , Proteínas Inactivadoras de Complemento/biosíntesis , Proteínas Inactivadoras de Complemento/genética , Secuencia de Consenso/genética , Pruebas Inmunológicas de Citotoxicidad/métodos , Citotoxicidad Inmunológica/genética , Regulación hacia Abajo/genética , Fibroblastos/inmunología , Fibroblastos/metabolismo , Citometría de Flujo , Humanos , Interferón gamma/metabolismo , Células K562 , Células Asesinas Naturales/metabolismo , Mutagénesis Sitio-Dirigida , Secuencias Repetitivas de Aminoácido/genética , Eliminación de Secuencia , Porcinos , TransfecciónRESUMEN
BACKGROUND: The pig pancreas is considered to be the most suitable source of islets for xenotransplantation into patients with type I diabetes. The purpose of this study was to assess the antigenicity of pig islets, including the Galalpha1-3Galbeta1-4GlcNAc-R (the alpha-Gal) and Hanganutziu-Deicher (H-D) antigens, and the pathway involved in human complement activation. METHODS: The expression of alpha-Gal on islets from adult pigs was investigated by immunohistochemical staining and flowcytometric analysis. The alpha1,3 galactosyltransferase (alpha1,3GT) activity of islets was determined by high-performance liquid chromatography. Antigenicity to human natural antibodies, including the H-D antigen of pig islets was next examined by treatment of pig islets with tunicamycin, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and/or neuraminidase. In addition, complement-mediated islets lysis was examined using factor D-deficient and C1-deficient sera. RESULTS: Adult pig islets expressed negligible amounts of alpha-Gal epitope, and alpha1,3GT activity was also undetectable. However, human natural antibodies, immunoglobulin G and M, and the anti H-D antibody react to the adult islet. Treatment of pig islets with tunicamycin, but not PDMP, led to a drastic reduction in antigenicity to human serum, indicating the importance of N-linked sugars on the islets. Neuraminidase treatment indicated the presence of, not only the H-D antigen, but also other sialic acid antigens that reacted with the human natural antibody. The complement deposition of C4, C3 and factor B on islets was demonstrated. The alternative pathway-mediated pig islet killing accounted for approximately 30% of that by the total complement pathway. CONCLUSION: The origin of antigenicity of pig islets is mainly N-linked sugars including sialic acid antigens, but not the alpha-Gal, and pig islets can be injured by both the classical and the alternative complement pathway in human serum.
Asunto(s)
Antígenos Heterófilos/inmunología , Islotes Pancreáticos/inmunología , Sistema del Grupo Sanguíneo ABO , Animales , Separación Celular , Disacáridos/inmunología , Galactosiltransferasas/análisis , Islotes Pancreáticos/citología , Islotes Pancreáticos/efectos de los fármacos , Islotes Pancreáticos/enzimología , Neuraminidasa/farmacología , Porcinos , Tunicamicina/farmacologíaRESUMEN
The cell membrane-bound forms of whole factor I (fI-PI), the light chain of the serine protease (SP) domain (SP-PI), and the light chain plus the COOH-terminal 45 amino acid (AA) of the heavy chain (SP+45-PI) were constructed. Chinese hamster ovary (CHO) cells, expressing these molecules were established by transfection of cDNA and confirmed by flow cytometry. Amelioration of complement-mediated cell lysis and complement fragment deposition on the cell surface by the transfectant molecules was tested in each CHO cell by means of a lactate dehydrogenase (LDH) assay and flow cytometry, respectively. A highly expressed fI-PI blocked human complement-mediated cell lysis by approximately 84% of the cells. CHO cell transfectants with SP-PI also showed a clear inhibition in cell lysis by human serum, whereas CHO cell transfectants with SP+45-PI showed no inhibition. In addition, fI-PI and SP-PI, but not SP+45-PI, suppressed C5b-9 deposition on CHO cell surface. These data indicate that the last 45 amino acid of the heavy chain, including a disulfide bridge area, did not participate in the serin protease function of factor I. The results suggest that SP-PI has potential for use in clinical xenotransplantation.
Asunto(s)
Membrana Celular/metabolismo , Fibrinógeno/química , Fibrinógeno/metabolismo , Serina Endopeptidasas/química , Serina Endopeptidasas/metabolismo , Animales , Células CHO , Proteínas del Sistema Complemento/química , Proteínas del Sistema Complemento/metabolismo , Cricetinae , Fibrinógeno/genética , Citometría de Flujo , Regulación de la Expresión Génica , Humanos , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Unión Proteica , Serina Endopeptidasas/genética , Transfección , Trasplante HeterólogoRESUMEN
The present paper describes production of cloned pigs from fibroblast cells of transgenic pigs expressing human decay accelerating factor (DAF, CD55) and N-acetylglucosaminyltransferase III (GnT-III) that remodels sugar-chain biosynthesis. Two nuclear transfer protocols were used: a two-step activation (TA) method and a delayed activation (DA) method. Enucleated in vitro-matured oocytes and donor cells were electrically fused in a calcium-containing medium by TA method or in a calcium-free medium by DA method, followed by electrical activation 1-1.5 h later, respectively. In vitro blastocyst formation rates of nuclear transferred embryos reconstructed by TA and DA method were 8% and 14%, respectively. As a result of embryo transfer of the reconstructed embryos made by each method into recipient pigs, both gave rise to cloned piglets. These cloned pigs expressed transgene as much as their nuclear donor cells. In conclusions, (1) pig cloning can be carried out by TA or DA nuclear transfer methods, (2) expression of transgenes can be maintained to cloned pigs from the nuclear donor cells derived from transgenic animals.
Asunto(s)
Blastocisto/citología , Antígenos CD55/genética , Clonación de Organismos/métodos , N-Acetilglucosaminiltransferasas/genética , Oocitos/citología , Animales , Animales Modificados Genéticamente , Transferencia de Embrión , Femenino , PorcinosRESUMEN
The significance of the envelope glycoprotein in the transmission of pig endogenous retrovirus (PERV) to human cells was investigated. Pig endothelial cells (PEC) were transduced with the LacZ gene by a pseudotype infection and then infected with PERV subtype B. Culture supernatants of the infected PEC previously incubated with several types of drugs were inoculated into HEK293 cells. The inoculated cells were then stained and the number of LacZ-positive foci was counted. PERV from tunicamycin treated PEC was not transmitted to human cells, indicating the importance of N-linked sugars in this process. Moreover, while inhibition of the terminal alpha-glucose residues from the precursor N-glycan by castanospermine and 1-deoxynojirimycin attenuated PERV infectivity, the mannosidase inhibitors, 1-deoxymannojirimycin and swainsonine, upregulated the infectivity. In addition, treatment with alpha-mannosidase and incubation with concanavalin A completely abrogated the transmission of PERV to HEK293. These data imply that the high-mannose type of N-glycan plays a key role in PERV infectivity.